High Avidity Anti-β2-Glycoprotein i Antibodies Activate Human Coronary Artery Endothelial Cells and Trigger Peripheral Blood Mononuclear Cell Migration
Anti-β2-glycoprotein I antibodies (aβ2GPI) represent a potential pathogenic candidate for coronary artery diseases. High avidity aβ2GPI (HAv aβ2GPI) are known to be associated with thrombotic and obstetric manifestations in patients with antiphospholipid syndrome, who are also susceptible to the dev...
Main Authors: | A. Artenjak, M. Koželj, K. Lakota, S. Čučnik, B. Božič, S. Sodin-Semrl |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2013-05-01
|
Series: | European Journal of Inflammation |
Online Access: | https://doi.org/10.1177/1721727X1301100209 |
Similar Items
-
Optimization of Unnicked β2-Glycoprotein I and High Avidity Anti-β2-Glycoprotein I Antibodies Isolation
by: Andrej Artenjak, et al.
Published: (2014-01-01) -
Naturally occurring antibodies against serum amyloid A reduce IL-6 release from peripheral blood mononuclear cells.
by: Tadeja Kuret, et al.
Published: (2018-01-01) -
Analysis of Drug Effects on Primary Human Coronary Artery Endothelial Cells Activated by Serum Amyloid A
by: K. Lakota, et al.
Published: (2018-01-01) -
Increased Responsiveness of Human Coronary Artery Endothelial Cells in Inflammation and Coagulation
by: Katja Lakota, et al.
Published: (2009-01-01) -
Colocalization of Serum Amyloid A with Microtubules in Human Coronary Artery Endothelial Cells
by: Katja Lakota, et al.
Published: (2011-01-01)